BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 19767072)

  • 1. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis.
    Gros E; Bussmann C; Bieber T; Förster I; Novak N
    J Allergy Clin Immunol; 2009 Oct; 124(4):753-60.e1. PubMed ID: 19767072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients.
    Park CO; Lee HJ; Lee JH; Wu WH; Chang NS; Hua L; Lee MG; Lee KH
    Exp Dermatol; 2008 Jan; 17(1):24-9. PubMed ID: 17979978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis.
    Kim HO; Cho SI; Chung BY; Ahn HK; Park CW; Lee CH
    Clin Exp Dermatol; 2012 Jul; 37(5):521-6. PubMed ID: 22680616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
    Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.
    Guttman-Yassky E; Lowes MA; Fuentes-Duculan J; Whynot J; Novitskaya I; Cardinale I; Haider A; Khatcherian A; Carucci JA; Bergman R; Krueger JG
    J Allergy Clin Immunol; 2007 May; 119(5):1210-7. PubMed ID: 17472813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
    Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
    J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
    Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
    J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis.
    Nomura I; Gao B; Boguniewicz M; Darst MA; Travers JB; Leung DY
    J Allergy Clin Immunol; 2003 Dec; 112(6):1195-202. PubMed ID: 14657882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
    J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
    Deguchi M; Aiba S; Ohtani H; Nagura H; Tagami H
    Arch Dermatol Res; 2002 Oct; 294(7):297-302. PubMed ID: 12373334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.
    Bilsborough J; Leung DY; Maurer M; Howell M; Boguniewicz M; Yao L; Storey H; LeCiel C; Harder B; Gross JA
    J Allergy Clin Immunol; 2006 Feb; 117(2):418-25. PubMed ID: 16461143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistological analysis of 'negative' patch test sites in atopic dermatitis.
    Buckley C; Poulter LW; Rustin MH
    Clin Exp Allergy; 1996 Sep; 26(9):1057-63. PubMed ID: 8889261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
    Wollenberg A; Sharma S; von Bubnoff D; Geiger E; Haberstok J; Bieber T
    J Allergy Clin Immunol; 2001 Mar; 107(3):519-25. PubMed ID: 11240954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesis.
    Roosje PJ; Whitaker-Menezes D; Goldschmidt MH; Moore PF; Willemse T; Murphy GF
    Am J Pathol; 1997 Oct; 151(4):927-32. PubMed ID: 9327725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions.
    Santegoets SJ; Gibbs S; Kroeze K; van de Ven R; Scheper RJ; Borrebaeck CA; de Gruijl TD; Lindstedt M
    J Leukoc Biol; 2008 Jul; 84(1):143-51. PubMed ID: 18436579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotyping of inflammatory cells in lesional skin of the extrinsic and intrinsic types of atopic dermatitis.
    Rho NK; Kim WS; Lee DY; Lee JH; Lee ES; Yang JM
    Br J Dermatol; 2004 Jul; 151(1):119-25. PubMed ID: 15270880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity.
    Oflazoglu E; Simpson EL; Takiguchi R; Grewal IS; Hanifin JM; Gerber HP
    Eur J Dermatol; 2008; 18(1):41-9. PubMed ID: 18086588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
    Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
    J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H; Takahashi M; Nakamura K; Kaneko F
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure.
    Pivarcsi A; Gombert M; Dieu-Nosjean MC; Lauerma A; Kubitza R; Meller S; Rieker J; Muller A; Da Cunha L; Haahtela A; Sonkoly E; Fridman WH; Alenius H; Kemeny L; Ruzicka T; Zlotnik A; Homey B
    J Immunol; 2004 Nov; 173(9):5810-7. PubMed ID: 15494534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.